Scientists have revealed the structure of a virus infecting bacteria that thrive in 160-degree hot springs in places like Yellowstone National Park in Wyoming. The discovery could lead to better targeted delivery of drugs into cells and new DNA sequencing technology, according to a study by ... more
Better biosensor technology created for stem cells
Technology may help guide treatment of Alzheimer's, Parkinson's diseases
A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer's and Parkinson's diseases and other neurological disorders.
The technology, which features a unique graphene and gold-based platform and high-tech imaging, monitors the fate of stem cells by detecting genetic material (RNA) involved in turning such cells into brain cells (neurons), according to a study in the journal Nano Letters.
Stem cells can become many different types of cells. As a result, stem cell therapy shows promise for regenerative treatment of neurological disorders such as Alzheimer's, Parkinson's, stroke and spinal cord injury, with diseased cells needing replacement or repair. But characterizing stem cells and controlling their fate must be resolved before they could be used in treatments. The formation of tumors and uncontrolled transformation of stem cells remain key barriers.
"A critical challenge is ensuring high sensitivity and accuracy in detecting biomarkers - indicators such as modified genes or proteins - within the complex stem cell microenvironment," said senior author KiBum Lee, a professor in the Department of Chemistry and Chemical Biology in the School of Arts and Sciences at Rutgers University-New Brunswick. "Our technology, which took four years to develop, has demonstrated great potential for analyzing a variety of interactions in stem cells."
The team's unique biosensing platform consists of an array of ultrathin graphene layers and gold nanostructures. The platform, combined with high-tech imaging (Raman spectroscopy), detects genes and characterizes different kinds of stem cells with greater reliability, selectivity and sensitivity than today's biosensors.
The team believes the technology can benefit a range of applications. By developing simple, rapid and accurate sensing platforms, Lee's group aims to facilitate treatment of neurological disorders through stem cell therapy.
Stem cells may become a renewable source of replacement cells and tissues to treat diseases including macular degeneration, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis and rheumatoid arthritis, according to the National Institutes of Health.
Rutgers researchers have created an automated blood drawing and testing device that provides rapid results, potentially improving the workflow in hospitals and other health-related institutions to allow health care practitioners to spend more time treating patients. "This device represents ... more
Rutgers University scientists have determined the three-dimensional structure of the target of the first-line anti-tuberculosis drug rifampin. They have also discovered a new class of potential anti-tuberculosis drugs that kill rifampin-resistant and multi-drug-resistant tuberculosis bacter ... more
- 1analytica 2020: New instruments for battery research
- 2Ultrafast birth of free radicals observed in water
- 3Looking at the good vibes of molecules: a new method for label-free metabolic imaging
- 4Eppendorf with new CEO dual leadership
- 5A fine sense for molecules
- 6Complete filling of batches of nanopipettes
- 7Sensing Protein Wellbeing
- 8Researchers create nanoscale sensors to better see how high pressure affects materials
- 9Watching complex molecules at work
- 102D materials: arrangement of atoms measured in silicene